TMAO promoted pyroptosis in cancer cells by activating the PERK kinase in the endoplasmic reticulum, leading to an increased immune response mediated by CD8+ T lymphocytes against tumors in triple-negative breast cancer in vivo. The gene discussed is EIF2AK3; the disease is triple-negative breast carcinoma.